Please provide your email address to receive an email when new articles are posted on . Altering the combined doses of dexmedetomidine and propofol impacts mortality risk in patients aged 65 years or ...
BACKGROUND: Dexmedetomidine is an α 2-receptor agonist used for sedation in the intensive care unit (ICU). Although dexmedetomidine is labeled for sedation in critically ill patients at doses up to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback